On ECHEMI
Home > Drugs > Changchun Haiwang Biological Pharmaceutical Co., Ltd.
Changchun Haiwang Biological Pharmaceutical Co., Ltd.
  • Founded in:

    1995-01-25
  • Country:

    China China
  • Address:

    No. 833, Huoju Road, Qianjin Street, High-tech Development Zone, Changchun City, Jilin Province;
  • Tax NO.:

    91220101243880532N
  • Registered Funds:

    20 million yuan
  • Website:

  • Email:

Related Drugs
Weikangling Capsules
White peony root, Bletilla striata, licorice, Poria cocos, Corydalis yanhusuo, cuttlebone, Panax notoginseng, and Belladonna extract.
Name Description Content CAS NO. Registered Holders
PAEONIAE RADIX ALBA

Comprehensively repair gastric mucosa, eliminate ulcers and inflammation of surrounding tissues

More

Comprehensively repair gastric mucosa, eliminate ulcers and inflammation of surrounding tissues

0
Bletillae Rhizoma

Hemostasis, comprehensive repair of gastric mucosa

More

Hemostasis, comprehensive repair of gastric mucosa

0
DGL

Acid reduction and comprehensive repair of gastric mucosa

More

Acid reduction and comprehensive repair of gastric mucosa

0
Poria

Comprehensive repair of gastric mucosa

More

Comprehensive repair of gastric mucosa

0
Yanhusuo

Analgesia

More

Analgesia

0
Cuttlebon(CuttlefishBone)Extract

Stop bleeding, reduce acid, and comprehensively repair gastric mucosa

More

Stop bleeding, reduce acid, and comprehensively repair gastric mucosa

0
NOTOGINSENG RADIX ET RHIZOMA

Hemostasis, comprehensive repair of gastric mucosa

More

Hemostasis, comprehensive repair of gastric mucosa

0
ExtracuM Belladonnae

Antispasmodic

More

Antispasmodic

0
Clarithromycin Tablets
The main ingredient of this product is clarithromycin.
Name Description Content CAS NO. Registered Holders
Clarithromycin

This product is a macrolide antibiotic, which has inhibitory effects on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus, and Pneumococcus, as well as some Gram-negative bacteria such as Haemophilus influenzae, Bordetella pertussis, Neisseria gonorrhoeae, Legionella pneumophila, and some anaerobic bacteria such as Bacteroides fragilis, Streptococcus peptostreptococcus, and Propionibacterium acnes. In addition, it also has inhibitory effects on mycoplasma. The characteristics of this product are that its antibacterial activity in vitro is similar to that of erythromycin, but its antibacterial activity in vivo against some bacteria such as Staphylococcus aureus, Streptococcus, and Haemophilus influenzae is stronger than that of erythromycin. There is cross-resistance between this product and erythromycin. The mechanism of action of this product is to inhibit the association of the 50S subunit of the nuclear protein and inhibit protein synthesis to produce an antibacterial effect.

More

This product is a macrolide antibiotic, which has inhibitory effects on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus, and Pneumococcus, as well as some Gram-negative bacteria such as Haemophilus influenzae, Bordetella pertussis, Neisseria gonorrhoeae, Legionella pneumophila, and some anaerobic bacteria such as Bacteroides fragilis, Streptococcus peptostreptococcus, and Propionibacterium acnes. In addition, it also has inhibitory effects on mycoplasma. The characteristics of this product are that its antibacterial activity in vitro is similar to that of erythromycin, but its antibacterial activity in vivo against some bacteria such as Staphylococcus aureus, Streptococcus, and Haemophilus influenzae is stronger than that of erythromycin. There is cross-resistance between this product and erythromycin. The mechanism of action of this product is to inhibit the association of the 50S subunit of the nuclear protein and inhibit protein synthesis to produce an antibacterial effect.

81103-11-9 46
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.